PT3378481T - Composto ou composição para previnir ou tratar infiltração gordurosa do pâncreas - Google Patents
Composto ou composição para previnir ou tratar infiltração gordurosa do pâncreasInfo
- Publication number
- PT3378481T PT3378481T PT168658060T PT16865806T PT3378481T PT 3378481 T PT3378481 T PT 3378481T PT 168658060 T PT168658060 T PT 168658060T PT 16865806 T PT16865806 T PT 16865806T PT 3378481 T PT3378481 T PT 3378481T
- Authority
- PT
- Portugal
- Prior art keywords
- fatty infiltration
- relieving
- diabetes
- preventing
- pancreas
- Prior art date
Links
- 238000001764 infiltration Methods 0.000 title 2
- 230000008595 infiltration Effects 0.000 title 2
- 210000000496 pancreas Anatomy 0.000 title 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 230000003902 lesion Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000024891 symptom Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562257707P | 2015-11-19 | 2015-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3378481T true PT3378481T (pt) | 2023-06-28 |
Family
ID=58717399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT168658060T PT3378481T (pt) | 2015-11-19 | 2016-11-21 | Composto ou composição para previnir ou tratar infiltração gordurosa do pâncreas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20180325840A1 (pt) |
| EP (1) | EP3378481B1 (pt) |
| JP (1) | JP6914256B2 (pt) |
| CN (1) | CN109715170A (pt) |
| DK (1) | DK3378481T3 (pt) |
| ES (1) | ES2949047T3 (pt) |
| FI (1) | FI3378481T3 (pt) |
| HU (1) | HUE062181T2 (pt) |
| PL (1) | PL3378481T3 (pt) |
| PT (1) | PT3378481T (pt) |
| TW (1) | TWI797068B (pt) |
| WO (1) | WO2017084631A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110269855A (zh) * | 2019-07-19 | 2019-09-24 | 辽宁大学 | 黄酮类小分子化合物在制备抑制胰脂肪酶活性药物中的应用 |
| JP2021161070A (ja) * | 2020-03-31 | 2021-10-11 | 花王株式会社 | Ｇｌｐ−１分泌促進剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380737A (en) * | 1989-05-04 | 1995-01-10 | Sterling Winthrop Inc. | Saccharin derivative proteolytic enzyme inhibitors |
| CN1840518A (zh) * | 2005-08-18 | 2006-10-04 | 山东寻山水产集团有限公司 | 一种从海带中提取甘露醇的方法 |
| JP2008007452A (ja) * | 2006-06-28 | 2008-01-17 | Ajinomoto Co Inc | 膵β細胞保護剤 |
| CN1911114B (zh) * | 2006-08-25 | 2012-08-15 | 李罡 | 一种含三氯蔗糖的饮料 |
| EP1925311A1 (en) * | 2006-11-15 | 2008-05-28 | Melbrosin International Produktions und Vertriebs GmbH & Co KG | Use of a plant extract or plant juice |
| JP5327732B2 (ja) * | 2007-08-31 | 2013-10-30 | 広島県 | α−グルコシダーゼ阻害剤及びその製造方法 |
| WO2010044371A1 (ja) * | 2008-10-16 | 2010-04-22 | 国立大学法人 群馬大学 | インスリン分泌促進剤 |
| EP2395985B1 (en) * | 2009-02-11 | 2016-07-27 | Ramot at Tel-Aviv University Ltd. | Antiseptic compositions comprising silver ions and menthol and uses thereof |
| IT1396074B1 (it) * | 2009-10-12 | 2012-11-09 | Axioma S R L | Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita' |
| EP2559346B1 (en) * | 2011-08-15 | 2014-03-26 | Symrise AG | Oleanene-type triterpene glycosides as masking agents |
| CN102920683B (zh) * | 2012-06-11 | 2013-08-14 | 江苏豪森药业股份有限公司 | 奥氮平口腔速溶膜 |
| CN104490611B (zh) * | 2014-12-12 | 2017-08-08 | 安徽新华学院 | 一种天然养发泡腾颗粒或泡腾片及其制备方法 |
-
2016
- 2016-11-21 DK DK16865806.0T patent/DK3378481T3/da active
- 2016-11-21 ES ES16865806T patent/ES2949047T3/es active Active
- 2016-11-21 JP JP2018526113A patent/JP6914256B2/ja active Active
- 2016-11-21 PT PT168658060T patent/PT3378481T/pt unknown
- 2016-11-21 HU HUE16865806A patent/HUE062181T2/hu unknown
- 2016-11-21 TW TW105138160A patent/TWI797068B/zh active
- 2016-11-21 WO PCT/CN2016/106607 patent/WO2017084631A1/zh active Application Filing
- 2016-11-21 FI FIEP16865806.0T patent/FI3378481T3/fi active
- 2016-11-21 CN CN201680067605.XA patent/CN109715170A/zh active Pending
- 2016-11-21 EP EP16865806.0A patent/EP3378481B1/en active Active
- 2016-11-21 US US15/777,385 patent/US20180325840A1/en active Pending
- 2016-11-21 PL PL16865806.0T patent/PL3378481T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201720461A (zh) | 2017-06-16 |
| JP2019511996A (ja) | 2019-05-09 |
| EP3378481A4 (en) | 2019-07-10 |
| CN109715170A (zh) | 2019-05-03 |
| US20180325840A1 (en) | 2018-11-15 |
| ES2949047T3 (es) | 2023-09-25 |
| WO2017084631A8 (zh) | 2018-09-13 |
| DK3378481T3 (da) | 2023-07-03 |
| JP6914256B2 (ja) | 2021-08-04 |
| EP3378481A1 (en) | 2018-09-26 |
| EP3378481B1 (en) | 2023-04-05 |
| WO2017084631A1 (zh) | 2017-05-26 |
| HUE062181T2 (hu) | 2023-09-28 |
| WO2017084631A9 (zh) | 2019-01-17 |
| TWI797068B (zh) | 2023-04-01 |
| PL3378481T3 (pl) | 2023-12-27 |
| FI3378481T3 (fi) | 2023-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1247096A1 (zh) | 治療痙攣疾病的組合物和方法 | |
| EP3395354A4 (en) | METHOD FOR PREVENTING AND TREATING DIABETIC NEPHROPATHY | |
| EP3501527A4 (en) | COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER, CONTAINING A VESICLE DERIVED FROM BACTERIA OF A SPECIES ACTOBACILLUS | |
| EP3474849A4 (en) | COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF DIABETES | |
| EP3298140A4 (en) | COMPOSITIONS FOR THE TREATMENT OF PATHOLOGICAL CALCIFICATION DISEASES AND METHODS OF USE THEREOF | |
| EP3246046A4 (en) | Agent for preventing and/or treating amyotrophic lateral sclerosis | |
| EP3193862A4 (en) | Cannabinoid composition and method for treating pain | |
| WO2014165090A8 (en) | Compounds for the treatment of tuberculosis | |
| PL3484862T3 (pl) | Związki, kompozycje i sposoby leczenia lub zapobiegania objawowi związanemu z dną moczanową lub hiperurykemią | |
| EP3395360A4 (en) | METHOD FOR PREVENTING OR TREATING DIABETIC RETINOPATHY | |
| EP3391902A4 (en) | A NEW METHOD FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASE | |
| EP3348557A4 (en) | COMPOUND FOR TREATING OR PREVENTING HYPERURICEMIA OR DROP | |
| EP3556383A4 (en) | INNOVATIVE METHOD FOR TREATING DIABETES | |
| EP3386594A4 (en) | COMPOSITIONS AND METHODS FOR TREATING MEDICATION RESISTANT MULTI-MEDIUM GLIOBLASTOMA | |
| EP3275450A4 (en) | Pharmaceutical composition for preventing or treating inflammatory diseases, containinglactococcus chungangensis | |
| EP3662914A4 (en) | SCAR PREVENTION OR TREATMENT COMPOSITION | |
| EP3359553A4 (en) | COMPOSITIONS AND METHODS OF TREATING DIABETIC RETINOPATHY | |
| EP3609522A4 (en) | METHODS AND COMPOUNDS FOR THE TREATMENT OF DIABETES | |
| EP2982378A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF SEPSIS OR SEPTIC SHOCK WITH ADK PROTEIN AS AN ACTIVE SUBSTANCE | |
| PT3378481T (pt) | Composto ou composição para previnir ou tratar infiltração gordurosa do pâncreas | |
| EP3181138A4 (en) | Composition for preventing or treating vascular leakage syndrome | |
| EP3354284A4 (en) | COMPOSITION FOR PAIN TREATMENT | |
| EP3226691A4 (en) | Composition and method for treating nematodes | |
| IL260331A (en) | Compounds and methods for the treatment of amyotrophic lateral sclerosis | |
| EP3305293A4 (en) | METHOD OF TREATING OR PREVENTING DIABETIC NEPHROPATHY |